22nd Century Group, Inc.(NYSE Amex Equities : XXII)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 2.59% | 282.27 | 1.4% | $841.66m | |
| AMGN | Amgen, Inc. | 1.08% | 220.86 | 1.3% | $515.75m | |
| CELG | Celgene Corp. | 0.00% | 110.02 | 1.3% | $466.76m | |
| GILD | Gilead Sciences, Inc. | 1.98% | 65.07 | 1.0% | $400.35m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.34% | 209.80 | 1.9% | $313.89m | |
| ILMN | Illumina, Inc. | 2.53% | 305.99 | 3.5% | $311.32m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.92% | 344.87 | 2.6% | $267.68m | |
| EXAS | EXACT Sciences Corp. | 3.55% | 82.05 | 24.0% | $209.78m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.34% | 108.37 | 2.0% | $179.80m | |
| SGEN | Seattle Genetics, Inc. | 1.29% | 114.75 | 6.1% | $136.96m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.71% | 75.04 | 4.3% | $123.64m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.05% | 97.46 | 14.6% | $115.38m | |
| A | Agilent Technologies, Inc. | 1.95% | 78.26 | 1.6% | $101.36m | |
| NBIX | Neurocrine Biosciences, Inc. | 2.89% | 113.05 | 5.0% | $90.40m | |
| BGNE | BeiGene Ltd. | 0.94% | 198.25 | 2.1% | $88.64m |
Company Profile
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.